Vascular actions of leukotrienes.
D000628:Aminophylline / Q000494:pharmacology; D000818:Animals; D001285:Atropine / Q000494:pharmacology; D001792:Blood Platelets / Q000187:drug effects; D001808:Blood Vessels / Q000187:drug effects / Q000502:physiology*; D002199:Capillary Permeability / Q000187:drug effects; D002927:Cimetidine / Q000494:pharmacology; D006145:Guanethidine / Q000494:pharmacology; D006584:Hexamethonium Compounds / Q000494:pharmacology; D006801:Humans; D007213:Indomethacin / Q000494:pharmacology; D008784:Methysergide / Q000494:pharmacology; D009119:Muscle Contraction / Q000187:drug effects; D009131:Muscle, Smooth, Vascular / Q000502:physiology; D011433:Propranolol / Q000494:pharmacology; D011738:Pyrilamine / Q000494:pharmacology; D012039:Regional Blood Flow / Q000187:drug effects; D013189:SRS-A / Q000494:pharmacology / Q000502:physiology*; D012867:Skin / Q000098:blood supply; D014661:Vasoconstriction
D006584:Hexamethonium Compounds; D013189:SRS-A; D000628:Aminophylline; D001285:Atropine; D002927:Cimetidine; D011433:Propranolol; D011738:Pyrilamine; D007213:Indomethacin; D008784:Methysergide; D006145:Guanethidine